Order results by:
Issue | Title | |
Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
"... evaluated. Results. Patients were divided into two groups according to DOAC therapy received. The main ..." | ||
Vol 18, No 6 (2022) | Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis | Abstract similar documents |
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev | ||
Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
"... Review presents data on medicines from the new group of cardiovascular drugs, direct oral ..." | ||
Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
"... incidence of pAF after intervention. Patients with pAF after CABG have a poor inhospital prognosis. ..." | ||
Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
"... significant differences between two groups, where some of them have shown superiority of DOACs especially ..." | ||
Vol 18, No 4 (2022) | Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants | Abstract similar documents |
D. V. Pevzner, N. S. Kostritca, A. K. Alieva, I. A. Merkulova, I. S. Yavelov, E. V. Merkulov, I. E. Chazova | ||
"... anticoagulants (DOACs) or warfarin. Material and methods. A prospective observational study included patients ..." | ||
Vol 19, No 3 (2023) | Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants | Abstract similar documents |
S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid | ||
"... to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical situations in which ..." | ||
Vol 18, No 3 (2022) | Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art | Abstract similar documents |
S. R. Gilyarevsky | ||
"... the efficacy and safety of the use of direct oral anticoagulants (DOACs) in clinical practice. Data on drug ..." | ||
Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
"... therapy with the addition of direct oral anticoagulants (DOAC). Material and methods. An open-label ..." | ||
Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
"... was inappropriate in accordance with the recommendations for the treatment of AF. In the group of patients with CHA2 ..." | ||
Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
"... ) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke ..." | ||
Vol 8, No 2 (2012) | SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY | Abstract similar documents |
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa | ||
"... . Patients were split into 2 groups: patients of group 1 (n=14) had syncope episodes during the last 24 hours ..." | ||
Vol 18, No 5 (2022) | Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
Z. A. Gebekova, I. I. Ivanov, A. Asambayeva, A. I. Skripka, A. A. Sokolova, D. A. Napalkov, T. A. Vuimo | ||
"... different direct oral anticoagulants (DOACs) using Thrombodynamics test. Materials and methods ..." | ||
Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
A. V. Panov | ||
"... of an anticoagulant and one antiplatelet, preferably from the group of P2Y12 inhibitors. When conducting combined ..." | ||
Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
Yu. P. Skirdenko, N. A. Nikolaev | ||
"... anticoagulants (DOACs) (χ2=1.44; p<0.49, Pearson) and significantly more in individuals taking warfarin ..." | ||
Vol 17, No 3 (2021) | Evaluation of Procalcitonin Levels in Patients with Various Forms of Acute Coronary Syndrome, Depending on the Presence of Adverse Hospital Outcomes | Abstract similar documents |
O. M. Drapkina, V. A. Zakharova | ||
"... by a large number of registered endpoints in general (24.1% vs. 6.6%, p<0.001), while in the group ..." | ||
Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
"... patients, including warfarin (39.5%), direct oral anticoagulants (DOAC) (46.5%) and low-molecular weight ..." | ||
Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
К. V. Lobastov, I. V. Schastlivtsev | ||
"... to alternative anticoagulants. Direct oral anticoagulants (DOACs) have changed the situation. Compared to VKA ..." | ||
Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
A. I. Kochetkov, O. D. Ostroumova | ||
"... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
"... to direct oral anticoagulants (DOACs). In randomized clinical trials, meta-analyses and systematic reviews ..." | ||
Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
O. V. Averkov, L. N. Mishchenko | ||
"... antagonists (warfarin) as well as direct oral anticoagulants (DOAC): dabigatran, rivaroxaban, apixaban ..." | ||
Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
"... with persistent nonvalvular atrial fibrillation receiving warfarin and direct oral anticoagulants (DOAC ..." | ||
Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
"... Aim. To study the frequency of administration of direct oral anticoagulant (DOACs) in doses ..." | ||
Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
"... compared with the group without AF. ACE inhibitors (ACEi) were prescribed in 127 cases (27.4%), angiotensin ..." | ||
Vol 16, No 1 (2020) | Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice | Abstract similar documents |
M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov | ||
"... groups of patients with diabetes combined with myocardial infarction (MI) and diabetes combined ..." | ||
Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
"... -Moscow, REGATA (Ryazan). The comparison groups consisted of 3016 (79.5%) patients with AF in combination ..." | ||
Vol 11, No 5 (2015) | Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders | Abstract similar documents |
B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov | ||
"... . The patients were divided into two groups according to the presence or absence of glucose metabolism disorders ..." | ||
Vol 20, No 4 (2024) | Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? | Abstract similar documents |
N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva | ||
"... regarding direct oral anticoagulants (DOAC) should be treated thoughtfully and carefully. When choosing ..." | ||
Vol 20, No 1 (2024) | Study of the course of recurrent myocardial infarction in the acute stage within the framework the hospital register | Abstract similar documents |
S. Yu. Martsevich, A. V. Zagrebelnyy, O. S. Afonina, I. M. Kuzmina, Yu. V. Avdeev, N. A. Muradyan, O. M. Drapkina | ||
"... were significantly older, more often had a disability group. Smoking and arterial hypertension were ..." | ||
Vol 13, No 1 (2017) | RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION | Abstract similar documents |
V. B. Kostogryz | ||
"... and small bleedings were not observed, as well as allergic reactions. In the group of patients who underwent ..." | ||
Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
"... and a history of MI (group “ACVA+MI” and 1530 patients had ACVA without history of MI (group “ACVA without MI ..." | ||
Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
"... oral anticoagulants (DOAC) prescription in clinical guidelines for venous thromboembolism (VTE) and AF ..." | ||
Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
"... no significant difference (p>0.05) contrary to the pronounced difference of thromboembolic risk in these groups ..." | ||
Vol 17, No 5 (2021) | Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries) | Abstract PDF (Eng) similar documents |
M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. M. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
"... ; 43.1% of men; CHA2DS2-VASc – 4.57±1.61 points; HAS-BLED – 1.60±0,75 points), and the group with AF ..." | ||
Vol 17, No 3 (2021) | Causes, Predisposing Factors and Prevention Directions of Drug-induced Bradycardia (Based on the Results of the Hospital Register of Oardiac Medications Overdoses STORM) | Abstract similar documents |
N. N. Nikulina, S. V. Seleznev, M. B. Chernysheva, S. S. Yаkushin | ||
"... characteristics of patients and the provision of medical care in the groups with AOD and ROD (p>0 ..." | ||
Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
"... prevention (p=0.050 and p=0.016, respectively). There were no differences with other age groups by endpoints ..." | ||
Vol 13, No 1 (2017) | EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 | Abstract similar documents |
L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin | ||
"... вмешательств (ЧКВ), медикаментозную и инвазивную терапию до выписки из стационара, а также госпитальные исходы ..." | ||
Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
"... prescribed group of lipid-lowering drugs was statins, while combined treatment or monotherapy with other ..." | ||
Vol 11, No 6 (2015) | RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD) | Abstract similar documents |
D. B. Nemick, G. V. Matyushin, A. V. Protopopov, S. A. Ustyugov, A. V. Shulmin | ||
"... the patients were divided into two groups: patients without COPD (952 persons; 83.2%) and those with COPD (160 ..." | ||
Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
"... The question of the safety of direct oral anticoagulants (DOACs), despite their high efficacy ..." | ||
Vol 13, No 6 (2017) | PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin | ||
"... of bleeding events were not found in Xa inhibitor groups. Conclusions. DOAC in patients with atrial ..." | ||
Vol 18, No 3 (2022) | Acute Kidney Injury after Transcatheter Aortic Valve Implantation | Abstract similar documents |
L. V. Kremneva, L. I. Gapon, S. V. Shalaev, D. V. Krasheninin | ||
"... ). ОПП диагностировали в соответствии с критериями KDIGO (2012). Оценивали следующие госпитальные ..." | ||
Vol 13, No 1 (2017) | LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER | Abstract similar documents |
S. Yu. Martsevich, Y. V. Semenova, N. P. Kutishenko, M. L. Ginzburg, A. V. Zagrebelnyy, A. V. Fokina, E. V. Daniels | ||
"... сравнение госпитальных регистров, проводимых в городе Люберцы: регистра острого ИМ ЛИС-1 (2005-2007 гг.) и ..." | ||
Vol 8, No 5 (2012) | THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE | Abstract similar documents |
S. Y. Marcevich, M. L. Ginzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. Y. Drozdova, E. V. Danijel's, A. V. Fokina | ||
Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
"... with STEMI. Main group patients immediately prior to sheath insertion took atorvastatin at a high dose (80 mg ..." | ||
Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
"... groups were comparable in risk score by CHA2DS2-VASc and HAS-BLED scales. Results. Patients with AF (n ..." | ||
Vol 21, No 2 (2025) | Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation | Abstract similar documents |
E. A. Naryshkina, M. I. Chashkina, E. S. Zadykyan, N. K. Kurnabalieva, E. M. Zakaryan, M. V. Serova, D. A. Andreev, A. G. Komarova, K. E. Eroshkin, A. A. Kulesh, D. A. Sychev | ||
"... .9% of patients, the prescribed doses of direct oral anticoagulant (DOAC) did not correspond to clinical ..." | ||
Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
"... This article affects the problems of using NOAC in the most defenseless groups of patients ..." | ||
Vol 12, No 6 (2016) | THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)." Part 1. Hospital Prospective Register of Patients after Acute Stroke (According to the Results of the Pilot Phase of the Study) | Abstract similar documents |
S. A. Boytsov, S. Yu. Martsevich, N. P. Kutishenko, M. M. Loukianov, A. E. Mitichkin, R. V. Viskov, L. V. Stakhovskaya, N. A. Shamalov, G. P. Arutyunov, I. V. Kokareva, N. E. Parsadanyan, M. I. Chernyshova, A. V. Zagrebelnyy, N. A. Dmitrieva, A. V. Akimova, G. I. Nikitina, O. V. Lerman, V. P. Voronina, E. N. Belova, E. N. Kudryashov, A. D. Deev | ||
"... отдаленные исходы, качество лекарственной терапии в рамках госпитального регистра. Материал и методы. На ..." | ||
Vol 17, No 6 (2021) | Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) | Abstract similar documents |
S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina | ||
Vol 20, No 3 (2024) | Predictors and etiology of in-hospital mortality in patients with acute myocardial infarction | Abstract PDF (Eng) similar documents |
T. H. Hoang, V. V. Maiskov, I. A. Merai, Z. D. Kobalava | ||
"... ) госпитальной летальности для пациентов острым инфарктом миокарда (ОИМ) после своевременно выполненной ранней ..." | ||
Vol 14, No 4 (2018) | Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research | Abstract PDF (Eng) similar documents |
A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee | ||
Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
O. D. Ostroumova, I. V. Goloborodova | ||
"... , and the development of osteoporosis. The high prevalence of atrial fibrillation and osteoporosis in older age groups ..." | ||
Vol 12, No 1 (2016) | Characteristic features, treatment and hospital outcomes in patients with acute myocardial infarction: Khabarovsk Register data. Part I | Abstract similar documents |
L. N. Malay, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, H. B. Garayev, A. Ya. Letskin | ||
Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
"... guidelines for the treatment of AH determine specific approaches for managing patients of older age groups ..." | ||
Vol 14, No 1 (2018) | THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES | Abstract similar documents |
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov | ||
"... достижении его целевых значений в амбулаторной и госпитальной практике. Материал и методы. В рамках ..." | ||
Vol 12, No 3 (2016) | EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD) | Abstract PDF (Eng) similar documents |
D. B. Nemik, G. V. Matyushin, A. V. Protopopov, A. V. Shulmin, S. A. Ustyugov | ||
"... ). Материал и методы. В одноцентровом ретроспективном исследовании проанализированы исходы госпитального этапа ..." | ||
Vol 16, No 2 (2020) | LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period | Abstract similar documents |
S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh | ||
Vol 20, No 4 (2024) | Comparison of the quality of logistic regression models and a classification tree in predicting hospital mortality in elderly patients with non-ST-elevation myocardial infarction | Abstract similar documents |
K. G. Pereverzeva, S. S. Yakushin, N. N. Peregudova, M. V. Mishutina | ||
"... классификации для прогнозирования госпитальной летальности у больных c инфарктом миокарда без подъема сегмента ..." | ||
Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
"... (ПОАК). Выбор конкретного препарата должен основываться на результатах рандомизированных клинических ..." | ||
Vol 13, No 2 (2017) | ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC | Abstract PDF (Eng) similar documents |
E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov | ||
"... терапии на госпитальном и амбулаторно-поликлиническом этапах, а также приверженность к медикаментозному ..." | ||
Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
"... statistics methods were used to evaluate the results. Results. In the study group a high frequency ..." | ||
Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
"... randomized into two groups. Patients of the first group received maintenance doses of acetylsalicylic acid ..." | ||
Vol 12, No 3 (2016) | ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS | Abstract PDF (Eng) similar documents |
R. A. Gajfulin, A. N. Sumin, O. G. Arhipov | ||
"... with ischemic heart disease (IHD) in different age groups. Material and methods. Patients (n=678) with IHD aged ..." | ||
Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
"... groups with a history of myocardial infarction by the example of outpatient cardiology institution ..." | ||
Vol 6, No 6 (2010) | WORKING GROUP OF THE YOUNG CARDIOLOGISTS HAS BEEN ESTABLISHED AT THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION | Abstract similar documents |
"... Working group of the Young Cardiologists has been established at the Society of Cardiology ..." | ||
Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
Vol 10, No 1 (2014) | ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW | Abstract similar documents |
O. N. Semenova, E. A. Naumova, Yu. G. Schwartz | ||
"... with adherence to treatment for chronic cardiovascular diseases in the group focused interview of patients ..." | ||
Vol 21, No 1 (2025) | Practical aspects of perioperative management in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants | Abstract similar documents |
E. N. Markova, T. Yu. Vedenikin, A. A. Kuzub, N. V. Kuchieva, A. R. Navasardyan, O. N. Dzhioeva | ||
"... fibrillation (AF) receiving direct oral anticoagulants (DOACs) and undergoing elective surgical interventions ..." | ||
Vol 11, No 1 (2015) | POMERANTSEV VLADIMIR PETROVICH (1925-2000) | Abstract similar documents |
"... Статью В.П. Померанцеву посвятил коллектив кафедры госпитальной терапии №1 лечебного факультета ..." | ||
Vol 14, No 3 (2018) | ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
D. B. Nemik, G. V. Matyushin, S. A. Ustyugov | ||
"... to intervention. The main group (SYNTAX Score ≤22 points) and the comparison group (SYNTAX Score index >22 points ..." | ||
Vol 6, No 6 (2010) | PROGNOSTIC VALUE OF PATHOLOGIC Q-WAVE AND TIME OF ITS APPEARANCE IN PATIENTS WITH MYOCARDIAL INFARCTION: COMPARISON STUDY | Abstract similar documents |
V. A. Shulman, S. E. Golovenkin, V. N. Simulin, V. V. Radionov, G. V. Matyushin | ||
"... were split up three groups depending on occurrence of pathologic Q-wave on ECG and time of its ..." | ||
Vol 13, No 3 (2017) | INFLUENCE OF PATIENTS’ PREHOSPITAL ATTENDANCE AT OUTPATIENT CLINICS ON LONG-TERM OUTCOMES OF ACUTE CORONARY SYNDROME: LIS-3 STUDY | Abstract similar documents |
Yu. V. Semenova, N. P. Kutishenko, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev, S. Yu. Martsevich | ||
"... to their rate of attendance at outpatient clinics all survived patients (n=320) were divided into 3 groups ..." | ||
Vol 8, No 5 (2012) | CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION | Abstract similar documents |
L. A. Bondarenko, L. E. Rudakova, F. K. Rakhmatullov, T. P. Kostrikova, I. I. Kapustina | ||
"... . Patients with STEMI (n=181) included in the study were split into two groups depending on the thrombolytic ..." | ||
Vol 10, No 2 (2014) | PREVALENCE RATE OF PSYCHOGENIC RISK FACTORS AMONG PATIENTS WITH ARTERIAL HYPERTENSION OF VARIOUS DEGREES ACCORDING TO CRITERIA OF EVIDENCE-BASED MEDICINE | Abstract similar documents |
B. B. Fishman, I. N. Kochanov, A. I. Horoshevskaja, M. A. Bobyr, D. A. Shamiladze, L. A. Fomenko, V. V. Kostirkina, Yu. O. Yevstyukhina | ||
"... , required an interdisciplinary approach to the therapy of this group of patients. ..." | ||
Vol 11, No 2 (2015) | Prof. V.V. Skibicky is 60! | Abstract similar documents |
"... , профессору, заведующему кафедрой госпитальной терапии Кубанского государственного медицинского университета. ..." | ||
Vol 9, No 5 (2013) | PROFESSOR SERGEY S. YAKUSHIN IS 60 | Abstract similar documents |
"... В августе отметил свой юбилей Сергей Степанович Якушин, профессор, заведующий кафедрой госпитальной ..." | ||
Vol 17, No 1 (2021) | Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease | Abstract similar documents |
O. A. Fomina, S. S. Yakushin | ||
"... into two groups: 103 patients (group 1; MINOCA) did not have obstructive involvement coronary arterial (CA ..." | ||
Vol 13, No 4 (2017) | COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE | Abstract similar documents |
E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov, V. V. Bobkov, D. Yu. Platonov | ||
"... % of patients in recombinant non-immunogenic staphylokinase group and in tenecteplase group, respectively (p=0 ..." | ||
Vol 16, No 5 (2020) | Thrombolytic Therapy in Normotensive Patients with Pulmonary Embolism (Data from the Retrospective Study) | Abstract similar documents |
N. A. Сherepanova, I. S. Mullova, A. R. Kiselev, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
"... groups: with thrombolysis (group 1) and without thrombolysis (group 2). Logistic regression analysis ..." | ||
Vol 12, No 3 (2016) | CLINICAL CASE OF THROMBOLYTIC THERAPY OF RECURRENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENT WITH LONG HISTORY OF ISCHEMIC HEART DISEASE | Abstract PDF (Eng) similar documents |
N. T. Vatutin, V. B. Kostogryz, A. I. Kostogryz, O. I. Stolika | ||
"... Приведенный клинический случай показывает эффективность и безопасность госпитального применения ..." | ||
Vol 7, No 5 (2011) | PRE-HOSPITAL THROMBOLYSIS IN KRASNOYARSK: RESULTS OF A RETROSPECTIVE COMPARATIVE STUDY | Abstract similar documents |
S. A. Skripkin, A. V. Lolenko, V. V. Radionov, M. V. Man'ko, A. E. Bulak | ||
"... госпитального тромболизиса препаратом алтеплаза. Материал и методы. Проведен ретроспективный сравнительный ..." | ||
Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
"... hours from the moment of admission to the hospital. The main group (n=23) from the first day ..." | ||
Vol 13, No 6 (2017) | ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES | Abstract similar documents |
Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich | ||
"... specific pharmacological groups of medications for primary and secondary cardiovascular diseases prevention ..." | ||
Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpygina | ||
"... groups. The patients were randomized into two groups: the group 1 (n=53) started treatment ..." | ||
Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpigina | ||
"... into randomized, an open-label comparative stepped trial. The patients were randomized into two groups: the group ..." | ||
Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
"... oral anticoagulants" or "direct oral anticoagulants" or "novel oral anticoagulant" or "NOAC" or "DOAC ..." | ||
Vol 12, No 6 (2016) | THE PROGNOSIS IN TRANSCATHETER AORTIC VALVE IMPLANTATION | Abstract similar documents |
T. E. Imaev, A. E. Komlev, R. S. Akchurin | ||
"... differences for all groups, p>0.05). Two-year survival was 77.5%, 82.5% and 82.7%, respectively (also ..." | ||
Vol 3, No 4 (2007) | RESULTS AND COMMENTS ON ADVANCE STUDY | Abstract similar documents |
S. R. Gilyarevsky | ||
"... ). Источник: ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on ..." | ||
Vol 3, No 5 (2007) | WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”? | Abstract similar documents |
S. R. Gilyarevsky | ||
"... Источник: Kjekshus J, Apetrei E, Barrios V, et al.; CORONA Group. Rosuvastatin in older patients ..." | ||
Vol 20, No 5 (2024) | Early intravenous beta-blockers injection in patients with acute STEMI: the results of the Russian registry REGION-IM | Abstract similar documents |
T. S. Sukhinina, M. A. Terenicheva, R. G. Gulyan, R. M. Shakhnovich, O. V. Stukalova, O. A. Saygina, I. S. Yavelov, D. V. Pevsner | ||
"... ) — non-cardiac cause of death, 0.3% (n=21) — the cause of death is not specified. In the group ..." | ||
Vol 19, No 1 (2023) | Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study | Abstract PDF (Eng) similar documents |
V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasilyeva, E. S. Ogibenina, E. E. Bykova, I. I. Shvedov, A. A. Ivannikov, N. A. Druzhinina | ||
"... ventilation. The hypertension group also had higher mortality. Age, hypertension, glucose, C-reactive ..." | ||
Vol 17, No 3 (2021) | Thrombolytic Therapy in Treatment in Patients with Pulmonary Embolism not High-risk: SIRENA Registry Data | Abstract similar documents |
N. A. Cherepanova, I. S. Mullova, T. V. Pavlova, A. D. Erlikh, O. L. Barbarash, S. A. Berns, E. A. Schmidt, D. V. Duplyakov | ||
"... of management of patients with not high-risk PE who received TLT (group 1), a selection of pairs of patients ..." | ||
Vol 15, No 1 (2019) | Prognostic Value of ECG in Patients with Pulmonary Embolism | Abstract similar documents |
I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
"... , dysfunction of the right ventricle. 443 patients (93.9%) without fatal outcome were the first group and 29 ..." | ||
Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
"... or more points) risks groups. Differences in clinical and anamnestic parameters, the peculiarities of DAPT ..." | ||
Vol 14, No 1 (2018) | OUTPATIENT REGISTRY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (PROFILE-IM): DATA ON PREHOSPITAL THERAPY IN COMPARISON WITH THE LIS-3 REGISTRY | Abstract similar documents |
N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov, S. Yu. Martsevich | ||
"... , according to both registries, refers to drugs from the statin group. ..." | ||
Vol 10, No 6 (2014) | VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE | Abstract PDF (Eng) similar documents |
N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge | ||
"... similar subscales of the SF-36 survey (in the total sample and in separated clinical groups. Discriminant ..." | ||
Vol 17, No 6 (2021) | Panic Attacks in Patients with Supraventricular Tachycardia: Problems of Differential Diagnosis and Impact on Quality of Life | Abstract PDF (Eng) similar documents |
D. A. Tsaregorodtsev, P. A. Shelukha, L. V. Romasenko, M. M. Beraya, A. V. Sokolov | ||
"... was diagnosed in the SVT group in 17 patients, accounting for 28.3%. Only 7 patients (41%) could clearly ..." | ||
Vol 7, No 5 (2011) | DYNAMICS OF ACUTE CORONARY SYNDROME PATIENT MANAGEMENT IN NONIVASIVE PRIMARY VASCULAR CENTER (ACCORDING TO RECORD AND RECORD-2 REGISTERS) | Abstract similar documents |
V. M. Provotorov, I. Shevchenko, R. Islamov | ||
"... Цель. Оценить изменения в характере госпитальном ведения больных с острым коронарным синдромом ..." | ||
1 - 100 of 779 Items | 1 2 3 4 5 6 7 8 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)